Schedule 13G ownership disclosure
SELLAS Life Sciences Group Inc
Common Stock, par value $0.0001 per share · CUSIP: 81642T209
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Anson Funds Management LP
Shares: 5,225,948 · Class: 4.9%
- Anson Management GP LLC
Shares: 5,225,948 · Class: 4.9%
- Tony Moore
Shares: 5,225,948 · Class: 4.9%
- Anson Advisors Inc.
Shares: 5,225,948 · Class: 4.9%
- Amin Nathoo
Shares: 5,225,948 · Class: 4.9%
- Moez Kassam
Shares: 5,225,948 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-109205
- Form type
- SCHEDULE 13G/A
- Filer
- Anson Funds Management LP
- CIK
- CIK 1491072
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership